Commentary by Carrie Mahowald MD
Case: GS, a 65 year old man with only a history of severe OA, is seen in pre-op clinic for medical clearance before his hip replacement. On his pre-op x-ray, …
Category: Endocrine
Clinical Correlations
Grand Rounds: “Insulin Resistance: Implications for Obesity, Type 2 Diabetes”
February 26, 2008
Commentary by Melissa Freeman MD, PGY2
This week’s Grand Rounds was delivered by Dr. Gerald Shulman, M.D., Ph.D., F.A.C.P. Professor of Internal Medicine and Cellular & Molecular Physiology and Investigator at the …
Bedside Rounds Series: Goiter
February 21, 2008Commentary by Kristin Remus MD, PGY-3, and Judith Brenner MD, Associate Program Director, NYU Internal Medicine Residency Program
The purpose of the physical diagnosis series is to review the origins, pathophysiology and actual techniques of common physical diagnoses. Our hopes are to renew interest in an area of medicine that is …
A New Path for the ACCORD (The Action to Control Cardiovascular Risk in Diabetes) trial: Does Being Sweeter Save Lives?
February 8, 2008
Commentary by Melissa Freeman MD, Endocrinology Section Editor
The ACCORD trial is an ongoing 5-year, North American, randomized study that began in 2001 to evaluate potential interventions to decrease cardiovascular (CV) events in …
Clinical Question: Pharmacology
December 28, 2007
Is there evidence to support the use of Lantus® (human insulin analog glargine) administered Q12h in Type 1 Diabetes?
Commentary by Kathy Lee, Pharmacy Resident
The goal of diabetes management is to reduce the …
Inpatient Diabetes Management: Case 7
December 20, 2007Commentary by Mary Vouyiouklis MD, Fellow, and Ann Danoff MD, Director, Division of Endocrinology, Diabetes and Metabolism, NYU Medical Center
Welcome to our final case of our special diabetes series intended to highlight the …
Inpatient Diabetes Management: Case 6
November 8, 2007
Commentary by Mary Vouyiouklis MD, Fellow, and Ann Danoff MD, Director, Division of Endocrinology, Diabetes and Metabolism, NYU Medical Center
Welcome to Case 6 of our special diabetes series intended to highlight the essentials of …
Targeting Triglycerides
October 31, 2007
Commentary by Josh Remick MD, PGY-3
Hypertriglyceridemia is defined by the NCEP guidelines for treatment as a fasting triglyceride level greater than 200 mg/dL after the target LDL-C level has been achieved (1). When triglyceride levels …